# ITIL-168 in Advanced Melanoma

> **NCT05050006** · PHASE2 · TERMINATED · sponsor: **Instil Bio** · enrollment: 29 (actual)

## Conditions studied

- Advanced Cutaneous Melanoma

## Interventions

- **BIOLOGICAL:** ITIL-168

## Key facts

- **NCT ID:** NCT05050006
- **Lead sponsor:** Instil Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-07
- **Primary completion:** 2023-02-27
- **Final completion:** 2023-02-27
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05050006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05050006, "ITIL-168 in Advanced Melanoma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05050006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*